Global Investigator-Initiated Research

The mission and purpose of the Investigator-Initiated Research (IIR) Program is to provide support for investigator-initiated research that advances medical and scientific knowledge about our products and that generates promising medical interventions. This global program is open to all researchers who are interested in conducting their own research.

Types of Research Eligible for Support:

• Clinical studies of approved and unapproved uses, involving approved or unapproved Pfizer drugs
• Observational studies, such as epidemiology studies and certain outcomes research studies where the primary focus is the scientific understanding of disease
• Other types of independent research on disease states, including novel diagnostic screening tools and surveys where Pfizer has no direct commercial interest
• In vitro or animal studies which include funding*

Pfizer support is typically provided in the manner of funding, and/or drug (either formulated or pure compound) depending upon the type of research.

If you are interested in discussing your research questions or ideas please contact your Pfizer representative. If you do not know whom to contact, please email us at iir@pfizer.com with your therapeutic area of interest and we will provide you with a contact.

*Pure compound-only requests that do not require funding should be submitted directly to the Pfizer Global Compound Transfer Group. For more information please click on the following link which will take you to the Global Compound Transfer Program on the Pfizer website.

For more information download our Investigator Initiated Research Program Details.

Pfizer also manages Competitive Grant Programs with specific research criteria and application timeframes, for more information please visit the Competitive Grant Programs.